American Journal of Advances in Nursing Research

INSULINOMA: A CASE STUDY

Mamta Choudhary , NarinderKaurWalia

mamta24.c@gmail.com

Insulinomas, Hyperinsulinemia, Hypoglycaemic.

Insulinomas are rare endocrine tumors with a prevalence of around 1 per 100,000 persons per year. Insulinomas accounts for approximately 40% of pancreatic endocrine tumors. Majority of the insulinomas are located in the pancreas or are attached directly to the pancreas. Fasting hypoglycemia in a healthy, well-nourished adult should raise the suspicion of insulinoma and trigger further investigation. Localization of the tumor is a challenge to clinicians. Surgical resection is the curative treatment with a high success rate. A 30-year-old Indian female, Mrs. X, experiencing hypoglycemic attacks characterized by dizziness, fatigue, sweating, and period of confusions associated with weight gain for 3 years, was admitted in selected Hospital of Punjab. She also had 2 episodes of tonicclonic seizures in past 10 months. Blood test revealed, a high plasma insulin level, and raised C- Peptide level. 72-hours fast test was introduced, which produced symptomatic hypoglycemia with hyperinsulinemia. Thyroid-stimulating hormone, liver function tests, creatinine, and electrolytes were normal. Abdomen CT scan didn’t present any lesions in pancreas whereas abdomen MRI revealed presence of the tumor, 1.5 cm in diameter, located in the tail of pancreas. She underwent successful distal pancreatectomy due to insulinoma, in March 2017 preserving the spleen and and splenic vessels. Six month follow up of patient shown subsided symptoms and no episode of Tonic Clonic Seizures post operatively. Insulinomas are neuroendocrine tumors are diseases of rare occurrence. It is difficult to have location conformed diagnosis with the readily available imaging methods because of borderline small size of lesions. Surgical resection is highly successful curative treatment.